← Evidence map

ArticleDiabetes & metabolic syndrome

Response to the letter to the editor submitted by Jaiswal A et al. (2020) regarding 'efficacy and safety of saroglitazar in managing hypertriglyceridemia in type-2 diabetes: A meta-analysis' (Dutta et al.).

Dutta D et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 33147557